These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24052010)

  • 21. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
    Koelbl O; Richter S; Flentje M
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1193-8. PubMed ID: 10613312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spot-scanning-based proton therapy for extracranial chordoma.
    Staab A; Rutz HP; Ares C; Timmermann B; Schneider R; Bolsi A; Albertini F; Lomax A; Goitein G; Hug E
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e489-96. PubMed ID: 21497457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
    Knäusl B; Fuchs H; Dieckmann K; Georg D
    Acta Oncol; 2016 Jun; 55(6):751-9. PubMed ID: 26750803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose to the developing dentition during therapeutic irradiation: organ at risk determination and clinical implications.
    Thompson RF; Schneider RA; Albertini F; Lomax AJ; Ares C; Goitein G; Hug EB
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):108-13. PubMed ID: 23332385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Outcomes and Prognostic Factors After Pencil-Beam Scanning Proton Radiation Therapy for Spinal Chordomas: A Large, Single-Institution Cohort.
    Snider JW; Schneider RA; Poelma-Tap D; Stieb S; Murray FR; Placidi L; Albertini F; Lomax A; Bolsi A; Kliebsch U; Malyapa R; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):226-233. PubMed ID: 29619966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma.
    McDonald MW; Linton OR; Moore MG; Ting JY; Cohen-Gadol AA; Shah MV
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):304-311. PubMed ID: 26519991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.
    Onimaru R; Shirato H; Shimizu S; Kitamura K; Xu B; Fukumoto S; Chang TC; Fujita K; Oita M; Miyasaka K; Nishimura M; Dosaka-Akita H
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):126-35. PubMed ID: 12694831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of leaf margins for lung stereotactic body radiotherapy using a flattening filter-free beam.
    Wakai N; Sumida I; Otani Y; Suzuki O; Seo Y; Isohashi F; Yoshioka Y; Hasegawa M; Ogawa K
    Med Phys; 2015 May; 42(5):2125-31. PubMed ID: 25979007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
    Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.
    Olsen JR; Moughan J; Myerson R; Abitbol A; Doncals DE; Johnson D; Schefter TE; Chen Y; Fisher B; Michalski J; Narayan S; Chang A; Crane CH; Kachnic L
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):400-408. PubMed ID: 28463160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of dose distribution in the 'Rind'--a volume outside the PTV--in 3-dimensional conformal radiation therapy of non-small cell lung cancer.
    McGibney C; Holmberg O; McClean B; Armstrong J
    Radiother Oncol; 2003 Jan; 66(1):87-93. PubMed ID: 12559525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anterior-oriented proton beams for prostate cancer: A multi-institutional experience.
    Cuaron JJ; Harris AA; Chon B; Tsai H; Larson G; Hartsell WF; Hug E; Cahlon O
    Acta Oncol; 2015 Jun; 54(6):868-74. PubMed ID: 25591937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy.
    Deville C; Jain A; Hwang WT; Woodhouse KD; Both S; Wang S; Gabriel PE; Christodouleas JP; Bekelman J; Tochner Z; Vapiwala N
    Acta Oncol; 2018 Nov; 57(11):1506-1514. PubMed ID: 30028227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility study of volumetric modulated arc therapy for the treatment of retroperitoneal sarcomas.
    Llacer-Moscardo C; Quenet F; Azria D; Fenoglietto P
    Radiat Oncol; 2010 Sep; 5():83. PubMed ID: 20854661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
    PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
    Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric and clinical predictors of acute esophagitis in lung cancer patients in Turkey treated with radiotherapy.
    Etiz D; Bayman E; Akcay M; Sahin B; Bal C
    Asian Pac J Cancer Prev; 2013; 14(7):4223-8. PubMed ID: 23991980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
    Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
    Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.